IL120561A0 - Peptides suitable for use in immunosuppressive therapy - Google Patents

Peptides suitable for use in immunosuppressive therapy

Info

Publication number
IL120561A0
IL120561A0 IL12056197A IL12056197A IL120561A0 IL 120561 A0 IL120561 A0 IL 120561A0 IL 12056197 A IL12056197 A IL 12056197A IL 12056197 A IL12056197 A IL 12056197A IL 120561 A0 IL120561 A0 IL 120561A0
Authority
IL
Israel
Prior art keywords
immunosuppressive therapy
peptides suitable
peptides
immunosuppressive
therapy
Prior art date
Application number
IL12056197A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL120561A0 publication Critical patent/IL120561A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12056197A 1996-04-24 1997-03-31 Peptides suitable for use in immunosuppressive therapy IL120561A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96201106 1996-04-24

Publications (1)

Publication Number Publication Date
IL120561A0 true IL120561A0 (en) 1997-07-13

Family

ID=8223915

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12056197A IL120561A0 (en) 1996-04-24 1997-03-31 Peptides suitable for use in immunosuppressive therapy

Country Status (20)

Country Link
US (1) US6184204B1 (xx)
EP (1) EP0920451A1 (xx)
JP (1) JP2000510106A (xx)
KR (1) KR20000010561A (xx)
CN (1) CN1216551A (xx)
AR (1) AR006813A1 (xx)
AU (1) AU719481B2 (xx)
BR (1) BR9708744A (xx)
CA (1) CA2251680A1 (xx)
CZ (1) CZ340698A3 (xx)
HU (1) HUP9901375A3 (xx)
IL (1) IL120561A0 (xx)
NO (1) NO984937L (xx)
NZ (1) NZ332427A (xx)
PL (1) PL329618A1 (xx)
RU (1) RU2199548C2 (xx)
TR (1) TR199802135T2 (xx)
TW (1) TW575583B (xx)
WO (1) WO1997040068A1 (xx)
ZA (1) ZA973071B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0103384A3 (en) 1998-07-23 2004-06-28 Akzo Nobel Nv Novel peptides for use in immunotherapy of autoimmune diseases
AU780238B2 (en) * 1999-10-18 2005-03-10 Akzo Nobel N.V. Modified peptides and peptidomimetics for use in immunotherapy
IL132611A0 (en) 1999-10-27 2001-03-19 Yeda Res & Dev Synthetic genes and polypeptides and pharmaceutical compositions comprising them
MXPA03001421A (es) 2000-08-14 2004-01-26 Johnson & Johnson Pirazoles sustituidos.
US7002985B2 (en) * 2001-01-16 2006-02-21 Motorola, Inc. Method and apparatus for organizing and scheduling multimedia data transfers over a wireless channel
EP1835027B1 (en) * 2004-12-07 2015-02-25 Toray Industries, Inc. Novel cancer antigen peptide and the use thereof
AU2006218237B2 (en) * 2005-02-28 2012-01-12 Bio-Y A/S YKL-40 monoclonal antibodies
FR2908654B1 (fr) * 2006-11-20 2014-04-04 Oreal Utilisation cosmetique de proteines de type chitinase
SI2172211T1 (sl) * 2008-10-01 2015-03-31 Immatics Biotechnologies Gmbh Sestavek s tumorjem povezanih peptidov in zadevnih cepiv proti raku za zdravljenje glioblastoma (GBM) in drugih vrst raka
RU2008140688A (ru) * 2008-10-15 2010-04-20 Михаил Аркадьевич Шурдов (RU) Иммуносупрессивный пептид
WO2010142041A1 (en) 2009-06-11 2010-12-16 The University Of Guelph Serine rich peptides having antioxidative stress properties
WO2011050471A1 (en) 2009-10-28 2011-05-05 University Of Manitoba Yellow pea seed protein-derived peptides
AU2011261107B2 (en) 2010-05-31 2016-04-14 London Health Sciences Centre Research Inc. RHAMM binding peptides
WO2018129261A1 (en) 2017-01-05 2018-07-12 Brown University Methods and compositions relating to anti-chi3l1 antibody reagents
US10766968B2 (en) 2017-08-23 2020-09-08 Brown University Methods and compositions relating to anti-CHI3L1 antibody reagents to treat cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2164498C (en) * 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39

Also Published As

Publication number Publication date
NO984937D0 (no) 1998-10-23
CZ340698A3 (cs) 1999-02-17
CA2251680A1 (en) 1997-10-30
RU2199548C2 (ru) 2003-02-27
WO1997040068A1 (en) 1997-10-30
JP2000510106A (ja) 2000-08-08
AU2768597A (en) 1997-11-12
HUP9901375A2 (hu) 1999-08-30
ZA973071B (en) 1998-08-05
NZ332427A (en) 2000-03-27
TW575583B (en) 2004-02-11
US6184204B1 (en) 2001-02-06
HUP9901375A3 (en) 2000-10-30
KR20000010561A (ko) 2000-02-15
AU719481B2 (en) 2000-05-11
AR006813A1 (es) 1999-09-29
PL329618A1 (en) 1999-03-29
TR199802135T2 (xx) 1999-01-18
BR9708744A (pt) 1999-08-03
CN1216551A (zh) 1999-05-12
NO984937L (no) 1998-12-01
EP0920451A1 (en) 1999-06-09

Similar Documents

Publication Publication Date Title
PL322589A1 (en) Radiotracer-labelled peptides for use in diagnostics and therapy
HK1096974A1 (en) Antibody against human parathormone related peptides
GB9609641D0 (en) Compounds useful in therapy
AP9700923A0 (en) Triazole derivatives useful in therapy
AU3804297A (en) Chair for use in construction
IL120561A0 (en) Peptides suitable for use in immunosuppressive therapy
GB2321191B (en) Peptides for use in wound treatment
GB2316976B (en) Improvements in clamps
DE69732623D1 (en) Analogsignalmultiplexer in strombetriebsart
GB2319076B (en) Improvements in firearms
EP0951543A4 (en) HUMAN GLYCIN VECTOR
GB9604400D0 (en) Compounds useful in therapy
AU3350097A (en) Immunocontraceptive methods and peptide or polypeptides for use in these methods
GB9623551D0 (en) Improvements in hairdressing
GB9512896D0 (en) Peptides for use in vaccines
PL104533U1 (en) Cryapplicator for use in cryosurgery
GB9608430D0 (en) Peptides
GB9625227D0 (en) Peptides
GB9605904D0 (en) Peptides
GB9606765D0 (en) Peptides
SG55039A1 (en) Peptides
GB9612648D0 (en) Peptides
GB9626362D0 (en) Peptides
AU5203998A (en) Peptides for use in wound treatment
GB9612813D0 (en) Improvements in chairs